 
        ISAKOS2017: IA TXA reduces postoperative bleeding in anterior cruciate ligament reconstruction
 
                                                    ISAKOS2017: IA TXA reduces postoperative bleeding in anterior cruciate ligament reconstruction
Intra-articular injection of tranexamic acid for reducing postoperative hemarthrosis in arthroscopic anterior cruciate ligament reconstruction
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
Synopsis
300 patients scheduled for anterior cruciate ligament reconstruction were randomized to either a topical tranexamic acid administration group or control group. Patients were assessed for postoperative blood loss to intraarticular drainage after 24 hours, as well as clinical outcome scores at 5 days and 4 weeks postoperatively. Blood loss results demonstrated a statistically significant, approximat...
                To view the full content, login to your account,
or start your 30-day FREE Trial today.
            
            FREE TRIAL
            LOGIN
            Forgot Password?
    Explore some of our unlocked ACE Reports below!
 
                Learn about our AI Driven 
 High Impact Search Feature
     
    Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue 
                     
                 
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         LOGIN
                                    LOGIN
                                 
            
Join the Conversation
Please Login or Join to leave comments.